Merck and Moderna to engage regulators on Intesimeran+Keytruda filing
Merck and Moderna said they will engage with regulators on filing submissions for intisimeran autogene in combination with Keytruda, according to TradeXchange Newsdesk.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.